153 related articles for article (PubMed ID: 26935991)
1. Perinatal Exposure to Neuregulin-1 Results in Disinhibition of Adult Midbrain Dopaminergic Neurons: Implication in Schizophrenia Modeling.
Namba H; Okubo T; Nawa H
Sci Rep; 2016 Mar; 6():22606. PubMed ID: 26935991
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model.
Schneider S; Götz K; Birchmeier C; Schwegler H; Roskoden T
Behav Brain Res; 2017 Mar; 322(Pt A):177-185. PubMed ID: 28089851
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease.
Carlsson T; Schindler FR; Höllerhage M; Depboylu C; Arias-Carrión O; Schnurrbusch S; Rösler TW; Wozny W; Schwall GP; Groebe K; Oertel WH; Brundin P; Schrattenholz A; Höglinger GU
J Neurochem; 2011 Jun; 117(6):1066-74. PubMed ID: 21517849
[TBL] [Abstract][Full Text] [Related]
4. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
5. Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia.
Kato T; Abe Y; Sotoyama H; Kakita A; Kominami R; Hirokawa S; Ozaki M; Takahashi H; Nawa H
Mol Psychiatry; 2011 Mar; 16(3):307-20. PubMed ID: 20142818
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window.
Nawa H; Sotoyama H; Iwakura Y; Takei N; Namba H
Biomed Res Int; 2014; 2014():697935. PubMed ID: 24949465
[TBL] [Abstract][Full Text] [Related]
7. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
8. A modeling study suggests complementary roles for GABAA and NMDA receptors and the SK channel in regulating the firing pattern in midbrain dopamine neurons.
Komendantov AO; Komendantova OG; Johnson SW; Canavier CC
J Neurophysiol; 2004 Jan; 91(1):346-57. PubMed ID: 13679411
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Neuregulin 1 Type III Confers Hippocampal mRNA Alterations and Schizophrenia-Like Behaviors in Mice.
Olaya JC; Heusner CL; Matsumoto M; Sinclair D; Kondo MA; Karl T; Shannon Weickert C
Schizophr Bull; 2018 Jun; 44(4):865-875. PubMed ID: 28981869
[TBL] [Abstract][Full Text] [Related]
10. Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1.
Yin DM; Chen YJ; Lu YS; Bean JC; Sathyamurthy A; Shen C; Liu X; Lin TW; Smith CA; Xiong WC; Mei L
Neuron; 2013 May; 78(4):644-57. PubMed ID: 23719163
[TBL] [Abstract][Full Text] [Related]
11. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.
Ledonne A; Nobili A; Latagliata EC; Cavallucci V; Guatteo E; Puglisi-Allegra S; D'Amelio M; Mercuri NB
Mol Psychiatry; 2015 Aug; 20(8):959-73. PubMed ID: 25266126
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse.
Okada M; Corfas G
Hippocampus; 2004; 14(3):337-44. PubMed ID: 15132433
[TBL] [Abstract][Full Text] [Related]
14. Post-pubertal Difference in Nigral Dopaminergic Cells Firing in the Schizophrenia Model Prepared by Perinatal Challenges of a Cytokine, EGF.
Namba H; Nawa H
Neuroscience; 2020 Aug; 441():22-32. PubMed ID: 32531471
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin 1 protects against ischemic brain injury via ErbB4 receptors by increasing GABAergic transmission.
Guan YF; Wu CY; Fang YY; Zeng YN; Luo ZY; Li SJ; Li XW; Zhu XH; Mei L; Gao TM
Neuroscience; 2015 Oct; 307():151-9. PubMed ID: 26318331
[TBL] [Abstract][Full Text] [Related]
16. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice.
Namba H; Zheng Y; Abe Y; Nawa H
Neuroscience; 2009 Feb; 158(4):1731-41. PubMed ID: 19041374
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of neuregulin action.
Talmage DA
Novartis Found Symp; 2008; 289():74-84; discussion 84-93. PubMed ID: 18497096
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses.
Hou XJ; Ni KM; Yang JM; Li XM
Neuroscience; 2014 Mar; 261():107-17. PubMed ID: 24374327
[TBL] [Abstract][Full Text] [Related]
20. Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.
Schmitt A; Parlapani E; Gruber O; Wobrock T; Falkai P
Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():35-9. PubMed ID: 18985292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
